NCT06818292View on ClinicalTrials.gov

Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

December 6, 2024

Study Completion Date

December 6, 2024

Conditions
Healthy
Interventions
BIOLOGICAL

Liraglutide

0.6 mg of the pre-filled solutions from pen-injector Liraglutide (GLP-1 Agonist)

BIOLOGICAL

Placebo

0.1 mL NaCl

Trial Locations (1)

07743

Department of Psychiatry and Psychotherapy, University Hospital Jena, Jena

All Listed Sponsors
collaborator

University Hospital, Bonn

OTHER

collaborator

Johann Wolfgang Goethe University Hospital

OTHER

lead

Nils Opel

OTHER

NCT06818292 - Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists | Biotech Hunter | Biotech Hunter